Enriched bioactive renal cell populations, characteristics and uses thereof
OwnerTimothy A. BERTRAM, Deepak JAINinventors
Life of this patent
Estimating the term…
Abstract
Methods of identifying an enriched heterogeneous renal cell population having therapeutic potential, enriched heterogeneous renal cell populations having therapeutic potential and uses for same.
Claims95
A method of identifying an enriched heterogeneous renal cell population as having a therapeutic potential, comprising:
- determining whether cells of the enriched heterogeneous renal cell population express at least one nephrogenic marker;
- and
- identifying the enriched heterogeneous renal cell population as having therapeutic potential if cells of the enriched heterogeneous renal cell population are determined to express the at least one nephrogenic marker;
- wherein the at least one nephrogenic marker comprises one or more of SIX2, OSR1, LHX1, RET and FGF8.
A method of identifying an enriched heterogeneous renal cell population as having a therapeutic potential, comprising:
- determining expression level of one or more of genes RHAMM, C2, C3, C4, fibrinogen, coagulation factor XIII, TEK, KDR, Notch1, Notch3, Timp3, Vwf, Adam15, Gas6, Igfbp1, and Tm4sf4 by cells of the enriched heterogeneous renal cell population;
- and
- identifying the enriched heterogeneous renal cell population as having therapeutic potential if the expression level of the one or more genes by cells of the enriched heterogeneous renal cell population is increased relative to expression level of the one or more genes by cells of a control renal cell population.
A method of identifying an enriched heterogeneous renal cell population as having a therapeutic potential, comprising:
- determining whether cells of the enriched heterogeneous renal cell population express SIX2, OSR1, RET and podocin;
- and
- identifying the enriched heterogeneous renal cell population as having therapeutic potential if cells of the enriched heterogeneous renal cell population are determined to express SIX2, OSR1, RET and podocin.
A method of identifying an enriched heterogeneous renal cell population as having a therapeutic potential, comprising:
- determining whether cells of the enriched heterogeneous renal cell population express nephrin, podocin and LHX1;
- and
- identifying the enriched heterogeneous renal cell population as having therapeutic potential if cells of the population express nephrin, podocin and LHX1.
Dependencies are inferred from the claim text.